| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 22 | 12 | |
| General health | 3 | 5 | |
| Back pain | 1 | 1 | |
| Chronic inflammatory demyelinating polyneuropathy | 1 | 0 | |
| Excessive daytime sleepiness (somnolence) | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Constipation | 1 | |
| Weight gain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 17 |
Member evaluations
asdf1179
evaluated on Dec 25, 2016
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: None
Lukasz
evaluated on Mar 08, 2016
- Perceived effectiveness for General health: Major
- Side effects: None